Abstract
Over a century ago, the two French neurologists Charcot and Marie and the English neurologist Tooth described a peripheral neuropathy. They had defined a clinical entity, which is now known as Charcot-Marie-Tooth disease (CMT) or hereditary motor and sensory neuropathy (HMSN). Neuropathies are diseases of the peripheral nervous system (PNS). Many of them are disorders with a genetic basis (hereditary motor and sensory neuropathy, HMSN) but geneticists still use the term Charcot-Marie-Tooth disease (CMT). CMT has a prevalence of 1:2500 and is divided into several groups on the basis of clinical, electrophysiological and histological criteria. CMT 1 is a disorder with hypertrophic nerves, reduced nerve conduction velocities (NCVs) and signs of de- and remyelination. Type 2 is characterized by normal NCVs and a decreased number of large myelinated fibers on nerve biopsy, suggesting that the pathology of the axon is the major cause of disease. Type 3 is an autosomal recessive disease and usually a more severe form of CMT 1. CMT 4 is also an autosomal recessive disorder with axonal and demyelinating pathology. CMT-X is a dominant X-linked form of CharcotMarie-Tooth disease, with severely affected males and, in many cases, females showing signs of a peripheral neuropathy.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Reiter, L. T., Murakami, T., Koeuth, T., Pentao, L., Muzny, D. M., Gibbs, R. A., Lupski, J. R. (1996) A recombination hotspot responsible for two inherited peripheral neuropathies is located near a mariner transposon-like element. Nat. Genet. 3, 288–297.
Valentijn, L. J., Baas, F., Wolterman, R. A., Hoogendijk, J. E., van den Bosch, N. H. A., Zorn, I., et al. (1992) Identical point mutations of the peripheral myelin protein gene PMP22 in Trembler-J mouse and Charcot-Marie-Tooth disease. Nat. Genet. 2, 288–291.
Nicholson, G. A., Valentijn, L. J., Cherryson, A. K., Bragg, T. L., DeKroon, R. M., Ross, D. A., et al. (1994) A frame shift mutation in the PMP22 gene in hereditary neuropathy with liability to pressure palsies. Nat. Genet. 6, 263–266.
Kulkens, T., Bolhuis, P. A., Wolterman, R., Kemp, S., te Nijenhuis, S., Valentijn, L. J., et al. (1993) Deletion of the codon for serine 34 from the major peripheral myelin protein P0 in Charcot-Marie-Tooth disease type 1B. Nature Genet. 5, 35–39.
Hoogendijk, J. E., Hensels, G. W., Gabreëls-Festen, A. A. W. M., Gabreëls, F. J. M., Jansen, E. A. M., de Jonghe, P., et al. (1992) De novo mutation in hereditary motor and sensory neuropathy type 1. Lancet 339, 1081–1082.
Stronach, E. A., Clarck, C., Bell, C., Lofgren, A., McKay, N. G., Timmerman, V., et al. (1999) A novel PCR based-based diagnostic tool for Charcot-Marie-Tooth Type 1A and Hereditary neuropathy with liability to pressure palsies. J. Peripheral Nerv. Syst. 4, 117–122.
Hensels, G. W, Janssen, E. A. M., Hoogendijk, J. E., Valentijn, L. J., Baas, F., and Bolhuis, P. A. (1993) Quantitative measurement of duplicated DNA as a diagnostic test for Charcot-Marie-Tooth disease type 1A. Clin. Chem. 39, 1845–1849.
Valentijn, L. J., Baas, F., Zorn, I., Hensels, G. W., de Visser, M., and Bolhuis, P. A. Alternatively sized duplication in Charcot-Marie-Tooth disease type 1A. Hum. Mol. Genet. 2, 2143–2146.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2003 Humana Press Inc.
About this protocol
Cite this protocol
Baas, F. (2003). Genetic Diagnosis of Charcot-Marie-Tooth Disease. In: Potter, N.T. (eds) Neurogenetics. Methods in Molecular Biology™, vol 217. Springer, Totowa, NJ. https://doi.org/10.1385/1-59259-330-5:177
Download citation
DOI: https://doi.org/10.1385/1-59259-330-5:177
Publisher Name: Springer, Totowa, NJ
Print ISBN: 978-0-89603-990-2
Online ISBN: 978-1-59259-330-9
eBook Packages: Springer Protocols